Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PWSC
2001
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $9.69M | ﹤0.01% |
455,111
+9,654
| +2% | +$219K |
|
|
INFN
2002
DELISTED
Infinera Corporation Common Stock
INFN
| $9.64M | ﹤0.01% |
1,599,468
+22,743
| +1% | +$114K |
|
2003
Napco Security Technologies
NSSC
$1.36B
| $9.64M | ﹤0.01% |
240,075
+4,175
| +2% | +$164K |
|
2004
Adeia
ADEA
$3.07B
| $9.63M | ﹤0.01% |
881,967
+12,546
| +1% | +$146K |
|
2005
4D Molecular Therapeutics
FDMT
$527M
| $9.63M | ﹤0.01% |
302,205
+33,567
| +12% | +$856K |
|
2006
Perimeter Solutions
PRM
$4.98B
| $9.63M | ﹤0.01% |
1,297,183
+155,528
| +14% | +$837K |
|
2007
United Natural Foods
UNFI
$2.87B
| $9.62M | ﹤0.01% |
837,179
+91,551
| +12% | +$1.33M |
|
2008
MannKind Corp
MNKD
$1.17B
| $9.61M | ﹤0.01% |
2,121,648
+54,804
| +3% | +$215K |
|
2009
Dine Brands
DIN
$458M
| $9.57M | ﹤0.01% |
205,917
+29,453
| +17% | +$1.37M |
|
2010
VSE Corp
VSEC
$5.81B
| $9.52M | ﹤0.01% |
118,990
+12,761
| +12% | +$872K |
|
2011
Mercado Libre
MELI
$96.3B
| $9.51M | ﹤0.01% |
6,291
+275
| +5% | +$450K |
|
|
BBT
2012
Beacon Financial Corp
BBT
$2.69B
| $9.47M | ﹤0.01% |
413,271
+51,381
| +14% | +$1.18M |
|
2013
CAVA Group
CAVA
$7.51B
| $9.46M | ﹤0.01% |
135,068
+11,033
| +9% | +$591K |
|
|
TGI
2014
DELISTED
Triumph Group
TGI
| $9.46M | ﹤0.01% |
628,902
+15,641
| +3% | +$233K |
|
2015
Nurix Therapeutics
NRIX
$2.41B
| $9.44M | ﹤0.01% |
642,190
+19,893
| +3% | +$214K |
|
2016
State Street SPDR Portfolio TIPS ETF
SPIP
$999M
| $9.44M | ﹤0.01% |
368,308
-26,566
| -7% | -$679K |
|
2017
Skyward Specialty Insurance
SKWD
$2.47B
| $9.42M | ﹤0.01% |
251,740
+19,096
| +8% | +$646K |
|
2018
Compass Minerals
CMP
$1.21B
| $9.39M | ﹤0.01% |
596,468
+46,976
| +9% | +$986K |
|
2019
Cooper-Standard Automotive
CPS
$538M
| $9.37M | ﹤0.01% |
565,609
-45,564
| -7% | -$731K |
|
|
PKST
2020
DELISTED
Peakstone Realty Trust
PKST
| $9.35M | ﹤0.01% |
579,610
+113,831
| +24% | +$1.75M |
|
2021
Arcus Biosciences
RCUS
$3.47B
| $9.31M | ﹤0.01% |
493,276
+21,094
| +4% | +$365K |
|
|
GLDD
2022
DELISTED
Great Lakes Dredge & Dock
GLDD
| $9.31M | ﹤0.01% |
1,064,066
-26,717
| -2% | -$220K |
|
2023
State Street Materials Select Sector SPDR ETF
XLB
$8.36B
| $9.29M | ﹤0.01% |
200,104
-1,432,606
| -88% | -$61.6M |
|
2024
SiriusPoint
SPNT
$2.75B
| $9.27M | ﹤0.01% |
729,668
-377,845
| -34% | -$4.5M |
|
2025
Argan
AGX
$8.31B
| $9.27M | ﹤0.01% |
183,454
+2,275
| +1% | +$107K |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.